PARIS, Oct 22 (Reuters) - Laboratory testing and diagnostics
company Eurofins set new financial targets for 2022 as
it expands its offering for coronavirus testing, while posting
third-quarter results on Thursday.
The company said it would expand such testing to include
influenza and respiratory viruses, hoping to achieve revenues of
5.7 billion euros ($6.8 billion) by 2022.
"The group is introducing 2022 objectives, as 2022 should
hopefully be the first year where the pandemic is brought under
control," Eurofins said in a statement.
(Reporting by Sudip Kar-Gupta; Editing by Clarence Fernandez)